{
    "id": "034bf68c-288b-4943-8ce7-045afa12b4ec",
    "indications": {
        "text": "ozurdex \u00ae corticosteroid indicated : treatment macular edema following branch retinal vein occlusion ( brvo ) central retinal vein occlusion ( crvo ) ( 1.1 ) treatment non-infectious uveitis affecting posterior segment eye ( 1.2 ) treatment diabetic macular edema ( 1.3 )",
        "doid_entities": [
            {
                "text": "macular edema (DOID:4449)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_4449"
            },
            {
                "text": "retinal vein occlusion (DOID:1727)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1727"
            },
            {
                "text": "central retinal vein occlusion (DOID:2450)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_2450"
            },
            {
                "text": "uveitis (DOID:13141)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_13141"
            },
            {
                "text": "diabetic macular edema (DOID:9191)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_9191"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "ophthalmic intravitreal injection . ( 2.1 ) intravitreal injection procedure carried controlled aseptic conditions . ( 2.2 ) following intravitreal injection , patients monitored elevation intraocular pressure endophthalmitis . ( 2.2 )",
        "doid_entities": [
            {
                "text": "endophthalmitis (DOID:4692)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_4692"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "ozurdex \u00ae ( dexamethasone intravitreal implant ) 0.7 mg supplied foil pouch 1 single-use plastic applicator , ndc 0023-3348-07. storage : store 15oc 30oc ( 59of 86of ) .",
    "adverseReactions": "ocular periocular infections ( 4.1 ) glaucoma ( 4.2 ) torn ruptured posterior lens capsule ( 4.3 ) hypersensitivity ( 4.4 )",
    "ingredients": [
        {
            "name": "DEXAMETHASONE",
            "code": "7S5I7G3JQL",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_41879"
        }
    ],
    "organization": "Allergan, Inc.",
    "name": "OZURDEX",
    "effectiveTime": "20250520",
    "indications_original": "OZURDEX \u00ae is a corticosteroid indicated for: The treatment of macular edema following branch retinal vein occlusion (BRVO) or central retinal vein occlusion (CRVO) ( 1.1 ) The treatment of non-infectious uveitis affecting the posterior segment of the eye ( 1.2 ) The treatment of diabetic macular edema ( 1.3 )",
    "contraindications_original": "For ophthalmic intravitreal injection. ( 2.1 ) The intravitreal injection procedure should be carried out under controlled aseptic conditions. ( 2.2 ) Following the intravitreal injection, patients should be monitored for elevation in intraocular pressure and for endophthalmitis. ( 2.2 )",
    "warningsAndPrecautions_original": "OZURDEX\n                     \n                        \u00ae\n                     \n                     \u00a0(dexamethasone intravitreal implant) 0.7 mg is supplied in a foil pouch with 1 single-use plastic applicator, NDC 0023-3348-07.\n                  \n                     Storage: Store at 15oC to 30oC (59oF to 86oF).",
    "adverseReactions_original": "Ocular or periocular infections ( 4.1 ) Glaucoma ( 4.2 ) Torn or ruptured posterior lens capsule ( 4.3 ) Hypersensitivity ( 4.4 )",
    "drug": [
        {
            "name": "OZURDEX",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_41879"
        }
    ]
}